Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 13.68 % |
3 Month Return | -3.47 % |
1 Year Return | + 72.36 % |
Market Stats | |
Previous Close | ₹83.25 |
Open | ₹83.70 |
Volume | 54.28L |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹4,607.74Cr |
P/E Ratio | 32.91 |
PEG Ratio | 21.79 |
Market Cap | ₹4,607.74 Cr |
P/B Ratio | 2.42 |
EPS | 1.89 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 13.29 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹4,607.74 Cr | 85.71% | 0.53 | ₹96 Cr | ₹1,690 Cr | |
NA | ₹435.76 Cr | 272.24% | 0.54 | ₹28 Cr | ₹601 Cr | |
NA | ₹15.41 Cr | 278.33% | 0.50 | NA | NA | |
BUY | ₹23,100.09 Cr | 3.59% | 0.52 | NA | NA | |
NA | ₹706.49 Cr | -0.07% | 0.57 | ₹9 Cr | ₹179 Cr |
Organisation | Morepen Laboratories Ltd |
Headquarters | Gurgaon |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Morepen Laboratories Ltd
Morepen Labs Launches Weight Management Program LightLife - 11 Dec, 2024
Dr. Morepen Launches Weight Management Product - 10 Dec, 2024
Morepen Labs Reports Strong Q2 Growth - 25 Nov, 2024
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 1 Year
In the last 1 year, MOREPENLAB has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Retail Holding Up
Retail Investor have increased holdings from 53.72% to 60.56% in Sep 2024 quarter
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 135.8% return, outperforming this stock by 67.6%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 35.65% of holdings in Sep 2024 quarter
Revenue Fall
Revenue is down for the last 2 quarters, 458.64 Cr → 442.71 Cr (in ₹), with an average decrease of 3.5% per quarter
Price Dip
In the last 7 days, MOREPENLAB stock has moved down by -4.8%
Profit Down
Netprofit is down for the last 2 quarters, 36.17 Cr → 34.85 Cr (in ₹), with an average decrease of 3.7% per quarter
FII Holding Down
Foreign Institutions have decreased holdings from 7.72% to 2.08% in Sep 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 35.65% | 0.00 | |
Foreign Institutions | 2.08% | ||
Mutual Funds | 0% | 157.14 | |
Retail Investors | 60.56% | 12.74 | |
Others | 1.71% |
Morepen Laboratories Ltd in the last 5 years
Lowest (10.48x)
March 23, 2020
Today (32.91x)
December 19, 2024
Industry (56.23x)
December 19, 2024
Highest (64.70x)
January 22, 2018
Morepen Laboratories Ltd’s net profit jumped 63.92% since last year same period to ₹34.85Cr in the Q2 2024-2025. On a quarterly growth basis, Morepen Laboratories Ltd has generated -3.65% fall in its net profits since last 3-months.
Read More about Earnings ResultsBearish
Neutral
Bullish
Morepen Laboratories Ltd is currently in a Bearish trading position according to technical analysis indicators.
Morepen Laboratories Ltd (MOREPENLAB) share price today is ₹79.89
Morepen Laboratories Ltd is listed on NSE
Morepen Laboratories Ltd is listed on BSE
PE Ratio of Morepen Laboratories Ltd is 32.91
PE ratio = Morepen Laboratories Ltd Market price per share / Morepen Laboratories Ltd Earnings per share
Today’s traded volume of Morepen Laboratories Ltd(MOREPENLAB) is 54.28L.
Today’s market capitalisation of Morepen Laboratories Ltd(MOREPENLAB) is ₹4607.74Cr.
Morepen Laboratories Ltd(MOREPENLAB | Price |
---|---|
52 Week High | ₹100.9 |
52 Week Low | ₹38.55 |
Morepen Laboratories Ltd(MOREPENLAB) share price is ₹79.89. It is down -20.82% from its 52 Week High price of ₹100.9
Morepen Laboratories Ltd(MOREPENLAB) share price is ₹79.89. It is up 107.24% from its 52 Week Low price of ₹38.55
Morepen Laboratories Ltd(MOREPENLAB | Returns |
---|---|
1 Day Returns | -3.36% |
1 Month Returns | 13.68% |
3 Month Returns | -3.47% |
1 Year Returns | 72.36% |